BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9916713)

  • 1. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
    J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
    Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
    Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.
    Berg KL; Carlberg K; Rohrschneider LR; Siminovitch KA; Stanley ER
    Oncogene; 1998 Nov; 17(19):2535-41. PubMed ID: 9824165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
    Cho HI; Park CG; Kim J
    Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells.
    Bryceson YT; Torgersen KM; Inngjerdingen M; Berg SF; Hoelsbrekken SE; Fossum S; Dissen E
    Eur J Immunol; 2005 Apr; 35(4):1230-9. PubMed ID: 15756648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
    Huyer G; Ramachandran C
    Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface expression of channel catfish leukocyte immune-type receptors (IpLITRs) and recruitment of both Src homology 2 domain-containing protein tyrosine phosphatase (SHP)-1 and SHP-2.
    Montgomery BC; Mewes J; Davidson C; Burshtyn DN; Stafford JL
    Dev Comp Immunol; 2009 Apr; 33(4):570-82. PubMed ID: 19013191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function.
    Carlyle JR; Martin A; Mehra A; Attisano L; Tsui FW; Zúñiga-Pflücker JC
    J Immunol; 1999 May; 162(10):5917-23. PubMed ID: 10229828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
    Qu CK; Feng GS
    Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.